Internal Medicine, Rheumatology · Philadelphia, PA
NPI
1912943044
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3400 Spruce St, 8 Penn Tower
Philadelphia, PA, 19104
Phone (215) 614-4401
Medicare paid, 2024
$52K
879 services
Medicare patients, 2024
220
Average age 73
Drug cost, 2024
$2.4M
1,511 prescriptions
Company payments, 2025
$17.62
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sharon Kolasinski was code 99215 (office e&m - established), 321 times for 166 patients. In total Sharon Kolasinski billed 879 services in 12 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 321 | 166 | $109.41 | $35K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 300 | 174 | $13.10 | $3,930 |
| 99214 Office E&M - Established | Facility | 84 | 66 | $73.34 | $6,160 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 59 | 35 | $23.03 | $1,359 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 54 | 45 | $12.32 | $665 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 13 | 11 | $26.39 | $343 |
By year: 2022 $44K for 505 services; 2023 $47K for 531 services; 2024 $52K for 879 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sharon Kolasinski prescribed most often to Medicare patients was Prednisone, with 199 prescriptions and refills. In total Sharon Kolasinski wrote 1,511 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 199 | 424 | 49 | $2,176 |
| Enbrel Sureclick Etanercept | 95 | 99 | Under 11 | $727K |
| Methotrexate Methotrexate Sodium | 91 | 210 | 27 | $2,272 |
| Omeprazole Generic | 81 | 215 | 26 | $839 |
| Xeljanz Tofacitinib Citrate | 75 | 83 | Under 11 | $434K |
| Hydroxychloroquine Sulfate Generic | 64 | 149 | 20 | $2,534 |
| Celecoxib Generic | 59 | 130 | 16 | $1,865 |
| Gabapentin Generic | 51 | 87 | 14 | $566 |
| Alendronate Sodium Generic | 42 | 98 | 11 | $487 |
| Leflunomide Generic | 39 | 103 | 14 | $3,150 |
| Tramadol Hcl Generic | 38 | 48 | Under 11 | $344 |
| Humira(Cf) Pen Adalimumab | 34 | 34 | Under 11 | $232K |
| Azathioprine Generic | 31 | 65 | Under 11 | $5,793 |
| Meloxicam Generic | 30 | 70 | Under 11 | $90.61 |
| Diclofenac Sodium Generic | 27 | 53 | 11 | $1,092 |
Brand drugs: - claims; generic drugs: 1,129 claims; opioid claims: 89.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharon Kolasinski $17.62 ($17.62 in general payments such as food, travel and fees) from 1 company. The largest payer was Otsuka America Pharmaceutical, Inc. with $17.62.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $17.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.